Other studies have also shown a favourable clinical outcome in cancer patients presenting CD4+ and CD8+ T cells specific for E. hirae, Bacteroides fragilis, Ruminococcaceae (131), and Akkermansia muciniphila (131–134). Here, CD8A is linked to cancer.